Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4045) 4045
science & technology (3754) 3754
life sciences & biomedicine (3676) 3676
female (3213) 3213
middle aged (2958) 2958
male (2914) 2914
aged (2732) 2732
oncology (2418) 2418
adult (2084) 2084
cancer (1955) 1955
chemoradiotherapy (1789) 1789
surgery (1765) 1765
treatment outcome (1711) 1711
chemotherapy (1589) 1589
retrospective studies (1564) 1564
neoplasm staging (1463) 1463
prognosis (1238) 1238
radiotherapy (1220) 1220
care and treatment (1174) 1174
aged, 80 and over (1137) 1137
disease-free survival (1109) 1109
survival rate (1012) 1012
chemoradiotherapy, adjuvant (922) 922
neoadjuvant therapy (921) 921
antineoplastic combined chemotherapy protocols - therapeutic use (912) 912
analysis (810) 810
follow-up studies (794) 794
medicine & public health (784) 784
radiation therapy (750) 750
kaplan-meier estimate (733) 733
combined modality therapy (716) 716
patients (704) 704
tumors (703) 703
adenocarcinoma - therapy (688) 688
chemoradiotherapy - methods (660) 660
survival analysis (636) 636
rectal neoplasms - therapy (626) 626
survival (614) 614
carcinoma, squamous cell - therapy (607) 607
colorectal cancer (574) 574
research (557) 557
rectal neoplasms - pathology (555) 555
esophageal neoplasms - therapy (534) 534
health aspects (523) 523
risk factors (523) 523
esophageal cancer (518) 518
radiology, nuclear medicine & medical imaging (511) 511
chemotherapy, adjuvant (509) 509
carcinoma, squamous cell - mortality (501) 501
adenocarcinoma - mortality (500) 500
hematology, oncology and palliative medicine (500) 500
adjuvant treatment (498) 498
cancer therapies (492) 492
adenocarcinoma - pathology (488) 488
rectal cancer (488) 488
metastasis (461) 461
young adult (461) 461
carcinoma, squamous cell - pathology (458) 458
rectal neoplasms - mortality (454) 454
squamous cell carcinoma (438) 438
gastroenterology & hepatology (421) 421
time factors (416) 416
patient outcomes (409) 409
multivariate analysis (407) 407
radiation (405) 405
proportional hazards models (403) 403
biological and medical sciences (400) 400
medical sciences (399) 399
esophageal neoplasms - pathology (392) 392
fluorouracil - administration & dosage (386) 386
cisplatin - administration & dosage (381) 381
radiotherapy, adjuvant (370) 370
abridged index medicus (367) 367
medical prognosis (364) 364
lymphatic metastasis (346) 346
esophageal neoplasms - mortality (343) 343
prospective studies (326) 326
mortality (318) 318
chemoradiotherapy - adverse effects (310) 310
radiotherapy dosage (299) 299
chemoradiotherapy, adjuvant - methods (283) 283
neoadjuvant therapy - methods (280) 280
antineoplastic agents - therapeutic use (275) 275
oncology, experimental (275) 275
otorhinolaryngology (275) 275
clinical trials (274) 274
usage (268) 268
adolescent (267) 267
toxicity (266) 266
cancer patients (264) 264
neoplasm recurrence, local (264) 264
neoplasm recurrence, local - pathology (263) 263
neoplasm recurrence, local - mortality (262) 262
pancreatic cancer (256) 256
surgical oncology (251) 251
nuclear radiation (250) 250
cohort studies (249) 249
medical research (246) 246
rectal neoplasms - surgery (246) 246
chemoradiotherapy - mortality (236) 236
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4296) 4296
German (49) 49
Japanese (19) 19
French (13) 13
Russian (11) 11
Chinese (5) 5
Portuguese (5) 5
Spanish (5) 5
Czech (2) 2
Hungarian (1) 1
Icelandic (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
by de Boer, Stephanie M and Powell, Melanie E and Mileshkin, Linda and Katsaros, Dionyssios and Bessette, Paul and Haie-Meder, Christine and Ottevanger, Petronella B and Ledermann, Jonathan A and Khaw, Pearly and Colombo, Alessandro and Fyles, Anthony and Baron, Marie-Helene and Jürgenliemk-Schulz, Ina M and Kitchener, Henry C and Nijman, Hans W and Wilson, Godfrey and Brooks, Susan and Carinelli, Silvestro and Provencher, Diane and Hanzen, Chantal and Lutgens, Ludy C H W and Smit, Vincent T H B M and Singh, Naveena and Do, Viet and D'Amico, Romerai and Nout, Remi A and Feeney, Amanda and Verhoeven-Adema, Karen W and Putter, Hein and Creutzberg, Carien L and McCormack, Mary and Whitmarsh, Karen and Allerton, Rozenn and Gregory, Deborah and Symonds, Paul and Hoskin, Peter J and Adusumalli, Madhavi and Anand, Anjana and Wade, Robert and Stewart, Alexandra and Taylor, Wendy and Kruitwagen, Roy F.P.M and Hollema, Harry and Pras, Elizabeth and Snyers, An and Stalpers, Lukas and Jobsen, Jan J and Slot, Annerie and Mens, Jan-Willem M and Stam, Tanja C and Van Triest, Baukelien and Van der Steen - Banasik, Elzbieta M and De Winter, Karin A.J and Quinn, Michael A and Kolodziej, Ilka and Pyman, Jan and Johnson, Carol and Capp, Anne and Fossati, Roldano and Gribaudo, Sergio and Lissoni, Andrea A and Ferrero, Annamaria and Artioli, Grazia and Davidson, Cathy and McLachlin, C. Meg and Ghatage, Prafull and Rittenberg, Paula V.C and Souhami, Luis and Thomas, Gillian and Duvillard, Pierre and Berton-Rigaud, Dominique and Tubiana-Mathieu, Nicole and PORTEC study group and PORTEC Study Grp
The lancet oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 295 - 309
no | Life Sciences & Biomedicine | Oncology | Science & Technology | Lymph Node Excision | Endometrial Neoplasms - mortality | Gynecologic Surgical Procedures - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Chemoradiotherapy, Adjuvant - adverse effects | Carcinoma, Endometrioid - therapy | Chemoradiotherapy, Adjuvant - mortality | Cisplatin - administration & dosage | Neoplasm Grading | Time Factors | Female | Paclitaxel - administration & dosage | Radiotherapy, Adjuvant | Gynecologic Surgical Procedures - mortality | Europe | Risk Factors | Carboplatin - administration & dosage | Treatment Outcome | New Zealand | Canada | Dose Fractionation, Radiation | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Endometrioid - mortality | Endometrial Neoplasms - therapy | Endometrial Neoplasms - pathology | Aged | Australia | Carcinoma, Endometrioid - radiotherapy | Neoplasm Staging | Carcinoma, Endometrioid - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
by Bosset, Jean-François, Prof and Calais, Gilles, Prof and Mineur, Laurent, MD and Maingon, Philippe, Prof and Stojanovic-Rundic, Suzana, MD and Bensadoun, René-Jean, Prof and Bardet, Etienne, MD and Beny, Alexander, MD and Ollier, Jean-Claude, MD and Bolla, Michel, Prof and Marchal, Dominique, MD and Van Laethem, Jean-Luc, Prof and Klein, Vincent, MD and Giralt, Jordi, MD and Clavère, Pierre, Prof and Glanzmann, Christoph, Prof and Cellier, Patrice, MD and Collette, Laurence, PhD and for the EORTC Radiation Oncology Group and EORTC Radiation Oncology Grp and EORTC Radiation Oncology Group
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 184 - 190
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Chemoradiotherapy, Adjuvant - adverse effects | Male | Chemoradiotherapy, Adjuvant - mortality | Young Adult | Neoadjuvant Therapy - mortality | Fluorouracil - administration & dosage | Time Factors | Adult | Female | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Digestive System Surgical Procedures - adverse effects | Rectal Neoplasms - therapy | Disease Progression | Rectal Neoplasms - mortality | Disease-Free Survival | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Intention to Treat Analysis | Aged | Israel | Neoplasm Staging | Digestive System Surgical Procedures - mortality | Adenocarcinoma - mortality | Nuclear radiation | Oncology, Experimental | Colorectal cancer | Adjuvant treatment | Research | Health aspects | Fluorouracil | Cancer | Index Medicus | Life Sciences | Cellular Biology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: Final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses
by Park, Se Hoon and Sohn, Tae Sung and Lee, Jeeyun and Lim, Do Hoon and Hong, Min Eui and Kim, Kyoung-Mee and Sohn, Insuk and Jung, Sin Ho and Choi, Min Gew and Lee, Jun Ho and Bae, Jae Moon and Kim, Sung and Kim, Seung Tae and Park, Joon Oh and Park, Young Suk and Lim, Ho Yeong and Kang, Won Ki
Journal of clinical oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 28, pp. 3130 - 3136
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymph Node Excision | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Chemoradiotherapy, Adjuvant - adverse effects | Male | Stomach Neoplasms - pathology | Chemoradiotherapy, Adjuvant - mortality | Young Adult | Time Factors | Gastrectomy - adverse effects | Adult | Female | Chemotherapy, Adjuvant | Republic of Korea | Gastrectomy - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Stomach Neoplasms - therapy | Treatment Outcome | Capecitabine - therapeutic use | Disease-Free Survival | Capecitabine - adverse effects | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
by Slagter, Astrid E and Jansen, Edwin P M and van Laarhoven, Hanneke W M and van Sandick, Johanna W and van Grieken, Nicole C T and Sikorska, Karolina and Cats, Annemieke and Muller-Timmermans, Pietje and Hulshof, Maarten C C M and Boot, Henk and Los, Maartje and Beerepoot, Laurens V and Peters, Frank P J and Hospers, Geke A P and van Etten, Boudewijn and Hartgrink, Henk H and van Berge Henegouwen, Mark I and Nieuwenhuijzen, Grard A P and van Hillegersberg, Richard and van der Peet, Donald L and Grabsch, Heike I and Verheij, Marcel
BMC cancer, ISSN 1471-2407, 2018, Volume 18, Issue 1, pp. 877 - 877
Follow-Up Studies | Stomach Neoplasms/mortality | Humans | Male | Treatment Outcome | Combined Modality Therapy | Chemotherapy, Adjuvant/methods | Antineoplastic Combined Chemotherapy Protocols/adverse effects | Neoplasm Metastasis | Neoplasm Grading | Chemoradiotherapy, Adjuvant/methods | Quality of Life | Female | Neoadjuvant Therapy/methods | Neoplasm Staging | Gastrectomy/methods | Chemotherapy | Resectable | Chemoradiotherapy | Gastric cancer | Surgery | Preoperative treatment | Life Sciences & Biomedicine | Oncology | Science & Technology | Stomach Neoplasms - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Stomach Neoplasms - pathology | Chemoradiotherapy, Adjuvant - methods | Gastrectomy - methods | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Stomach Neoplasms - mortality | Usage | Care and treatment | Perioperative care | Analysis | Adjuvant treatment | Clinical trials | Radiotherapy | Comparative analysis | Stomach cancer | Cancer | Medical research | Relapse | Medicine, Experimental | Patient compliance | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Adjuvant chemotherapy for advanced endometrial cancer
by Galaal, Khadra and Al Moundhri, Mansour and Bryant, Andrew and Lopes, Alberto D and Lawrie, Theresa A and Galaal, Khadra
Cochrane library, ISSN 1469-493X, 2014, Volume 2018, Issue 12, pp. CD010681 - CD010681
CANCER OF THE UTERINE BODY | Antineoplastic Combined Chemotherapy Protocols | Endometrial Neoplasms | Chemoradiotherapy | Doxorubicin | Uterine body | Initial management | Cisplatin | Randomized Controlled Trials as Topic | Gynaecology | Gynaecological | Surgery | Paclitaxel | Disease‐Free Survival | Chemotherapy, Adjuvant | Neoplasm Staging | Radiotherapy, Adjuvant | Medicine General & Introductory Medical Sciences | Cancer | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Endometrial Neoplasms - mortality | Humans | Cisplatin - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - adverse effects | Chemotherapy, Adjuvant - methods | Endometrial Neoplasms - therapy | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Female | Paclitaxel - administration & dosage | Chemotherapy, Adjuvant - mortality | Doxorubicin - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Transoral laser microsurgery (TLM) ± adjuvant therapy for advanced stage oropharyngeal Cancer: Outcomes and prognostic factors
by Rich, Jason T and Milov, Simon and Lewis Jr, James S and Thorstad, Wade L and Adkins, Douglas R and Haughey, Bruce H
The Laryngoscope, ISSN 0023-852X, 09/2009, Volume 119, Issue 9, pp. 1709 - 1719
P16 | Tonsil | Transoral laser microsurgery | Advanced stage oropharyngeal cancer | Human papilloma virus | Tongue base | Chemoradiotherapy | Biological and medical sciences | Medical sciences | Otorhinolaryngology. Stomatology | Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology | Tumors | Lymph Node Excision | Prognosis | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Male | Oropharyngeal Neoplasms - pathology | Tongue Neoplasms - surgery | Tongue Neoplasms - drug therapy | Deglutition | Aged, 80 and over | Adult | Female | Laser Therapy - methods | Chemotherapy, Adjuvant | Tongue Neoplasms - mortality | Tonsillar Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Postoperative Period | Treatment Outcome | Tonsillar Neoplasms - surgery | Tonsillar Neoplasms - mortality | Tongue Neoplasms - pathology | Oropharyngeal Neoplasms - surgery | Survival Analysis | Tonsillar Neoplasms - drug therapy | Aged | Microsurgery - methods | Neoplasm Staging | Index Medicus | tongue base | tonsil | p16 | chemoradiotherapy | human papilloma virus | advanced stage oropharyngeal cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
by Matei, Daniela and Filiaci, Virginia and Randall, Marcus E and Mutch, David and Steinhoff, Margaret M and DiSilvestro, Paul A and Moxley, Katherine M and Kim, Yong M and Powell, Matthew A and O’Malley, David M and Spirtos, Nick M and Small, William and Tewari, Krishnansu S and Richards, William E and Nakayama, John and Matulonis, Ursula A and Huang, Helen Q and Miller, David S
The New England journal of medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 24, pp. 2317 - 2326
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Prognosis | Endometrial Neoplasms - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Treatment Outcome | Chemoradiotherapy, Adjuvant | Neoplasm, Residual | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endometrial Neoplasms - surgery | Statistics, Nonparametric | Aged, 80 and over | Endometrial Neoplasms - therapy | Quality of Life | Adult | Endometrial Neoplasms - pathology | Female | Aged | Chemotherapy, Adjuvant | Neoplasm Staging | Endometrial cancer | Vagina | Oncology | Metastasis | Radiation therapy | Patients | Cancer therapies | Survival | Quality of life | Abdomen | Chemotherapy | Platinum | Computer centers | Endometrium | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Adjuvant chemotherapy and Overall survival in adult medulloblastoma
by Kann, Benjamin H and Lester-Coll, Nataniel H and Park, Henry S and Yeboa, Debra N and Kelly, Jacqueline R and Baehring, Joachim M and Becker, Kevin P and Yu, James B and Bindra, Ranjit S and Roberts, Kenneth B
Neuro-oncology (Charlottesville, Va.), ISSN 1522-8517, 2017, Volume 19, Issue 2, pp. 259 - 269
Adult | Chemotherapy | Survival | Medulloblastoma | Radiation | Oncology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Medulloblastoma - mortality | Chemoradiotherapy, Adjuvant - mortality | Young Adult | Medulloblastoma - radiotherapy | Radiotherapy, Adjuvant - mortality | Medulloblastoma - pathology | Aged, 80 and over | Female | Cerebellar Neoplasms - pathology | Chemotherapy, Adjuvant - mortality | Cerebellar Neoplasms - drug therapy | Craniospinal Irradiation - mortality | Cerebellar Neoplasms - mortality | Survival Rate | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged | Medulloblastoma - drug therapy | Neoplasm Staging | Cerebellar Neoplasms - radiotherapy | Index Medicus | Clinical Investigation | adult | medulloblastoma | radiation | chemotherapy | survival
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients
by Hautmann, Richard E and de Petriconi, Robert C and Pfeiffer, Christina and Volkmer, Bjoern G
European urology, ISSN 0302-2838, 2012, Volume 61, Issue 5, pp. 1039 - 1047
Urology | Cystectomy | Bladder neoplasms | Mortality | Stage | Neobladder | Urothelial carcinoma | Survival | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Lymph Node Excision | Urinary Bladder Neoplasms - mortality | Prognosis | Follow-Up Studies | Carcinoma - surgery | Humans | Middle Aged | Carcinoma - mortality | Male | Survival Rate | Treatment Outcome | Lymphatic Metastasis | Chemoradiotherapy, Adjuvant | Urinary Bladder Neoplasms - surgery | Young Adult | Disease-Free Survival | Urinary Diversion - methods | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Aged | Cystectomy - methods | Care and treatment | Carcinoma | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Utility of up‐front transoral robotic surgery in tailoring adjuvant therapy
by Gildener–Leapman, Neil and Kim, Jeehong and Abberbock, Shira and Choby, Garret W and Mandal, Rajarsi and Duvvuri, Umamaheswar and Ferris, Robert L and Kim, Seungwon
Head & neck, ISSN 1043-3074, 08/2016, Volume 38, Issue 8, pp. 1201 - 1207
transoral robotic surgery (TORS) | adjuvant therapy | oropharyngeal squamous cell carcinoma (OPSCC) | decision‐making | oropharynx | decision-making | Oropharyngeal Neoplasms - therapy | Prognosis | United States | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Robotic Surgical Procedures - mortality | Carcinoma, Squamous Cell - surgery | Male | Oropharyngeal Neoplasms - pathology | Patient Care Planning | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Neoplasm Invasiveness - pathology | Adult | <